Clarivate

MARCH 14, 2024

With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. Future research could focus on developing PFAS-free packaging materials that meet regulatory standards without compromising safety.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

OCTOBER 5, 2022

An industry that is among the world’s biggest polluters is caught in a balancing act between satisfying the health and safety demands of industry regulators and meeting the needs of modern eco-conscious consumers. But how is this push shaping the pharma packaging market and what are the key changes we can expect to see?

Pharma 84

Pharma Safety Pharmaceutical Manufacturing 84

Pharmaceutical Technology

MARCH 22, 2023

Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety. He adds that in the early 2000s there were no set standards for RFID in the pharma industry, so the compatibility between systems was not guaranteed.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma FDA 105

European Pharmaceutical Review

JULY 25, 2022

As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. In fact, the most recent estimate from the World Customs Organization places the global fake pharma market at $200 billion.

Pharmaceutical 82

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 82

European Pharmaceutical Review

FEBRUARY 1, 2024

Dr Michael Davidson is CEO of biotech company NewAmsterdam Pharma. We are hopeful that NewAmsterdam Pharma is part of that solution with obicetrapib.” NewAmsterdam Pharma is moving forward into our Phase III trials in the high LDL populations and ultimately, we want to show the benefit of obicetrapib on reducing cardiovascular events.

Pharma 74

Pharma Patients Pharmaceutical Leads 74

pharmaphorum

SEPTEMBER 28, 2022

Payers must take into consideration not only the clinical efficacy of a drug, but also its safety profile, side effects, and cost-effectiveness, among other factors. According to Ross Selby, Head of Global Patient Access at Takeda Oncology via NICE : “Uncertainty is the prime reason that medicines struggle with HTA.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. The demand for commercial CAR products is very high due to its unprecedented success in treatment of patients with very advanced haematological malignancies.

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83

World of DTC Marketing

SEPTEMBER 28, 2020

As you all know Trump has promised a vaccine shortly before the election while Secretary Azar barred the nation’s health agencies, including the Food and Drug Administration, from signing any new rules regarding the nation’s foods, medicines, medical devices and other products, including vaccines.

Food and Drug Administration 163

Food and Drug Administration Pharma Side effects Food 163

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. Pharma 4.0. In the fast-approaching era of Pharma 4.0,

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical products Manufacturing Pharmaceutical 52